Found 6 matching trials
Evaluate the Safety and Efficacy of 48-Hour Infusions of HNO (Nitroxyl) Donor in Hospitalized Patients With Heart Failure PHASE2 A Study to Evaluate Safety and Efficacy of Continuous 48-Hour Intravenous I...
Show More Location
University of Arizona Sarver Heart Center
Learn More & Join Trial
A Dose Ranging Phase IIa Study of 6 Hour Intravenous Dosages of CXL-1427 in Patients Hospitalized With Heart Failure PHASE2 A randomized, double-blinded, placebo-controlled study of continuous 6-hour...
Show More Location
Cardioxyl Study Site
Learn More & Join Trial
An Investigational Study of Continuous 8-Hour Intravenous Administrations of BMS-986231 in Participants With Heart Failure and Reduced Heart Function Given a Standard Dose of Loop Diuretic PHASE2 The purpose of this study is to investigate continuous 8-hour introductions...
Show More Location
Glasgow Clinical Research Facility
Learn More & Join Trial
A First-in-Human Study of the Safety of Single Continuous Intravenous (IV) Infusions of CXL-1427 for up to 48 Hours in Healthy Volunteers PHASE1 This study is designed to assess a safe dosage of the drug CXL-1427 (BMS-98...
Show More Location
Multiple Locations
Learn More & Join Trial
Study With Healthy Japanese and Non-Asian Participants With BMS-986231 PHASE1 The purpose of this Phase 1 study is to evaluate the safety, tolerability, ...
Show More Location
West Coast Clinical Trials, Llc
Learn More & Join Trial
A Study of Continuous Infusions of HNO (Nitroxyl) Donor in Patients With Heart Failure and Impaired Systolic Function PHASE2 The purpose of this study is to evaluate the effects of BMS-986231 on systo...
Show More Location
Orange County Research Center
Learn More & Join Trial